Mostrando 4 resultados de: 4
Filtros aplicados
Finerenone: A potential treatment for patients with chronic kidney disease and type 2 diabetes Mellitus
ReviewAbstract: Type 2 diabetes mellitus (T2DM) affects an estimated 463 million people worldwide, equivalent to 1 iPalabras claves:cardiovascular diseases, Chronic kidney disease, Diabetic nephropathies, FinerenoneAutores:D’marco L., Forquet C., Gandía L., Giménez-Civera E., Juan-García I., Panizo N., Puchades M.J., Reque J., Teruel J.L., Valmore BermúdezFuentes:scopusEpicardial adipose tissue, adiponectin and leptin: A potential source of cardiovascular risk in chronic kidney disease
ReviewAbstract: The importance of cardiometabolic factors in the inception and progression of atherosclerotic cardioPalabras claves:adiponectin, Cardiovascular disease, Epicardial adipose tissue, leptinAutores:D’marco L., Lima-Martínez M., Puchades M.J., Raggi P., Romero-Parra M., Soto C., Teruel J.L., Valmore BermúdezFuentes:scopusPathogenic mechanisms of SARS-CoV-2 infection and kidney disease: a clinical and molecular perspective
ArticleAbstract: The SARS-CoV-2 infection has become as a worldwide public health emergency. It exhibits a variety ofPalabras claves:acute kidney injury, Angiotensin-conver-ting enzyme 2, Chronic kidney disease, covid-19, SARS-COV-2Autores:D’marco L., Guerra-Torres X.E., Lameda V., Manzano A., Medina O., Morillo V., Nava M., Parra H., Puchades M.J., Suarez M.K., Torres W., Valmore BermúdezFuentes:scopusInsulin withdrawal in diabetic kidney disease: What are we waiting for?
ArticleAbstract: The prevalence of type 2 diabetes mellitus worldwide stands at nearly 9.3% and it is estimated thatPalabras claves:Cardiovascular disease, Diabetic kidney disease, GLP-1RA, Insulin, SGLT2iAutores:D’marco L., Gorriz-Zambrano C., Morillas C., Puchades M.J., Solá-Izquierdo E., Teruel J.L., Valmore BermúdezFuentes:scopus